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Kingdom
While it is expected for gene length to be associated with factors such as intron number 
and evolutionary conservation, we are yet to understand the connections between gene 
length and function in the human genome. In this study, we show that, as expected, there 
is a strong positive correlation between gene length, transcript length, and protein size 
as well as a correlation with the number of genetic variants and introns. Among tissue-
specific genes, we find that the longest transcripts tend to be expressed in the blood 
vessels, nerves, thyroid, cervix uteri, and the brain, while the smallest transcripts tend to 
be expressed in the pancreas, skin, stomach, vagina, and testis. We report, as shown 
previously, that natural selection suppresses changes for genes with longer transcripts 
and promotes changes for genes with smaller transcripts. We also observe that genes 
with longer transcripts tend to have a higher number of co-expressed genes and protein-
protein interactions, as well as more associated publications. In the functional analysis, 
we show that bigger transcripts are often associated with neuronal development, while 
smaller transcripts tend to play roles in skin development and in the immune system. 
Furthermore, pathways related to cancer, neurons, and heart diseases tend to have genes 
with longer transcripts, with smaller transcripts being present in pathways related to 
immune responses and neurodegenerative diseases. Based on our results, we hypothesize 
that longer genes tend to be associated with functions that are important in the early 
development stages, while smaller genes tend to play a role in functions that are important 
throughout the whole life, like the immune system, which requires fast responses.
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INTRODUCTION
With the sequencing of the human genome (Lander et al., 2001; Venter et al., 2001; International 
Human Genome Sequencing Consortium, 2004) arose a great interest in understanding the 
relationship between genotype and phenotype, especially concerning human health (Gonzaga-
Jauregui et al., 2012; Goldfeder et al., 2017). However, despite the recent advancements, we have 
yet to fully understand the human genome and its complexity (Simonti and Capra, 2015).
Several studies have tried to decipher the connections between the length of a gene and 
its functions. It is believed that genes that are more evolutionarily conserved are often associated 
with longer gene length and higher intronic burden (Wolf et  al., 2009; Vishnoi et  al., 2010; 
Gorlova et  al., 2014; Grishkevich and Yanai, 2014). In contrast, a shorter gene length is 
associated with a high expression, smaller proteins, and little intronic content (Urrutia and 
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Hurst, 2003). This hypothesis is further supported by 
housekeeping genes, which are widely expressed and have 
characteristics similar to genes with shorter length (Eisenberg 
and Levanon, 2003). It was hypothesized that, due to the great 
levels of expression in smaller genes, there is selective pressure 
to maximize protein synthesis efficiency (Urrutia and Hurst, 
2003). If that is the case, then the question remains regarding 
which functions benefit longer genes to compensate for their 
more expensive production of proteins.
Gene length has been associated with biological timing. 
In response to stimuli, smaller genes produce proteins faster, 
and these smaller proteins often play a part in the regulation 
of longer proteins, which, in turn, are expressed later in 
the response. This allows for regulatory mechanisms to 
be  set up in preparation for the expression of important 
proteins (Kirkconnell et al., 2017). Indeed, longer genes have 
been associated with important biological processes, including 
embryonic development (Yang et  al., 2018) and neuronal 
processes (Sahakyan and Balasubramanian, 2016). Longer 
genes have also been previously shown to be  related to 
diseases such as cancer, cardiomyopathies, and diabetes 
(Sahakyan and Balasubramanian, 2016).
In this work, we  used human genome data to identify 
possible functions associated with gene size, with a focus on 
protein-coding regions and genes. Correlation tests were used 
to identify relationships between gene length and other gene 
and protein characteristics. We  observed that longer genes are 
expressed in the brain, heart diseases, and cancer, while smaller 
genes mostly participate in the immune system and in the 
development of the skin. Therefore, we  hypothesize, based on 
our results, that genes with longer transcripts are mostly 
associated with functions in the early development stages, while 
genes with smaller transcripts have important roles in 
day-to-day functions.
MATERIALS AND METHODS
Data Retrieval and Filtering
All protein-coding human transcripts and genes 
(Ntranscripts  =  92,696), their length, transcript count, and GC 
content were obtained using the BioMart (Zerbino et al., 2018) 
website (GRCh38.p12, Ensembl 96, April 2019). Transcript 
length is defined by Ensembl as the total length of the exons 
in a gene plus the lengths of its untranslated (UTR) regions. 
Gene length was obtained using the R (version 3.5.2) packages 
biomart (version 2.38.0) and GenomicRanges (version 1.34.0) 
and based on the code for the getGeneLengthAndGCContent 
function of the EDASeq (version 2.14.1) package. To avoid 
any discrepancies between how Ensembl defines transcript 
length and our calculated gene length, we  extracted the start 
and end positions for all exons+UTR regions of all transcripts 
and calculated gene length based on the combined length 
between those regions. Using R, the transcripts with the highest 
transcript length per gene were selected. In the case of ties, 
due to multiple transcripts having the same length per gene, 
we  used some tags (APPRIS annotation was the principal one, 
if there was an entry in RefSeq or GENCODE) used by Ensembl 
as a tiebreaker. Should that fail, the oldest transcript was chosen, 
by means of having a smaller numerical ID. Transcripts associated 
with PATCH locations or assemblies were removed from our 
dataset. For each transcript, we  obtained data regarding their 
number of exons, coding sequence (CDS) length, the number 
of single nucleotide polymorphisms (SNPs), synonymous 
(“synonymous_variant”), missense (“missense_variant“), and 
nonsense (“stop_gained”) SNPs, protein length, and the dN 
and dS values using the biomart package. For the dN and dS 
values, only those associated with one-to-one orthologs were 
selected for the present analysis. Average expression was obtained 
from the USCS Table browser tool (Karolchik et  al., 2004) 
using expression as the group and the GTEx Gene track. 
Tissue-specific tau values of expression were obtained from 
another work (Palmer et  al., 2019). The number of SNPs per 
gene was obtained using the biomart package and website.
The whole file produced and used in the analysis for this 
work can be  found in Supplementary Table S1 (N  =  19,714).
A second dataset was built using the APPRIS annotation 
(Rodriguez et al., 2013) provided by Ensembl. Transcripts were 
first selected for each gene, based on whether they were identified 
as the principal isoform. Transcripts with entries in RefSeq 
were used as a tiebreaker. Should there still be  duplicates, the 
oldest transcript was used. This dataset can be  found in 
Supplementary Table S2A (N  =  19,702).
Genes related with aging (N  =  307) were obtained from 
GenAge (Build 19; Tacutu et  al., 2018).
Statistical Tests, Graphs, and Other Packages
R and the function corr.test were used to perform the correlation 
tests. Due to the abundance of data, there were a lot of ties 
in the ranks, which prevented the usage of Spearman’s correlation, 
so instead we chose to use the Kendall test for the correlations. 
Partial correlations were done using the ppcor (version 1.1) 
package. For multivariable regression, the lm function in R 
was used based on the following formula: Number of PPI ~ 
Transcript Length  +  Number of publications. The figures 
produced in this work were created using the ggplot2 (version 
3.2.0) package in R. The other packages used over the course 
of this work were: corrplot (version 0.84), psych (version 
1.9.12.31), ggpubr (version 0.2.1), cowplot (version 1.0.0), stringr 
(version 1.4.0), dplyr (version 0.8.5), plyr (version 1.8.4), and 
tidyr (version 0.8.3).
Functional Analysis
WebGestalt (2019 release; Liao et  al., 2019) was used to do 
the overrepresentation enrichment analysis for each of the Gene 
Ontology (GO) categories (biological process, cellular component, 
and molecular function). The top  5% genes, with the highest 
and the lowest gene lengths, were ran against the reference 
option of genome. The significance level was FDR  <  0.05 and 
the multiple test adjustment was done using the Benjamini-
Hochberg method.
For confirmation of the results, the same two 5% lists were 
run on DAVID’s (Huang et  al., 2009a,b) annotation clustering 
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option using the complete human genome as background. Only 
those terms with a value of p and false discovery rate (FDR) 
smaller or equal to 0.05 were considered. Default categories 
were used, except for the category “UP_SEQ_FEATURE” since 
it was introducing a lot of redundant results.
To help better visualize the GO terms obtained from the 
analysis described above, the tool REViGO (Supek et al., 2011) 
was used. The values of p here considered were the FDR 
values obtained previously, with the human database option 
used for the GO terms.
With regard to the analysis done using the Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathways, the grouping of 
genes with pathways was obtained from the Molecular Signature 
database (version 6.2; Kanehisa and Goto, 2000; Subramanian 
et  al., 2005; Liberzon et  al., 2011, 2015; Kanehisa et  al., 2017, 
2019), as was done previously by another group (Sahakyan 
and Balasubramanian, 2016). For each gene, the length used 
was that of the corresponding transcript from our dataset. 
Additionally, the coloring of the box plot was done based on 
the fact that the pathway in question is directly associated 
with the category (when the KEGG pathway schematic shows 
cells from the category) or if they could be indirectly associated 
with the category (using available literature). For this latter 
case, the appropriate literature was selected if the said literature 
mentioned elements of the KEGG pathway being involved in 
the said category. The categorization on the basis of published 
work has its advantages, but there is often overlapping of 
functions within these categories; for example, calcium signaling 
also happens in the muscle (Kuo and Ehrlich, 2015) and 
immune system (Vig and Kinet, 2009), the Wnt signaling 
pathway also has a role in cancer (Zhan et  al., 2017), and 
the TGF-beta signaling pathway can also be  associated with 
the immune system (Worthington et  al., 2012), among others.
While the KEGG pathways used in this work did not 
incorporate all of the genes in our dataset, these KEGG pathways 
were considered canonical by the MSigDB (Subramanian et al., 
2005; Liberzon et al., 2015), which would provide more certainty 
that our results are genuine by removing a lot of the ambiguity 
around the existence of several of our genes.
To further our understanding of the influence of gene length 
in the immune system, we analyzed data from Reactome (version 
75; Jassal et  al., 2019). Data were extracted based on the 
ontology levels. If we  assume that the immune system is the 
first ontology level, then the second level would include its 
child terms (innate immune system, adaptive immune system, 
and cytokine signaling), with the third level including the child 
terms of the second level, and so on.
Co-Expression Analysis
Co-expression correlation values were extracted from 
GeneFriends (van Dam et al., 2015). For each gene (N = 19,714), 
in the whole dataset and in the top  5% lists of genes with 
the longest (High group) and the smallest (Low group) transcript 
lengths (N  =  986 for each list), the number of genes with 
correlation values superior or equal to 0.6 or smaller or equal 
to −0.6 were obtained using R. From our original dataset 
(N = 19,714 genes), 1,046 genes were not present in GeneFriends 
(whole dataset), of which 25 missing genes were within the 
High group and 110 missing genes were within the Low group.
For obtaining the median values of genes present in the 
GeneFriends database, the co-expression values for each gene 
across the database were merged, and this was followed by 
the calculation of median values using R.
Protein-Protein Interaction Analysis
BioGRID (release 3.5.174) REST API (Stark, 2006), in 
combination with the R package httr (version 1.4.0), was used 
to obtain all protein-protein interactions for the whole dataset 
and for the top  5% longest and smallest genes. All redundant 
and genetic interactions were removed from this analysis.
For the publication bias analysis, the number of publications, 
in PubMed, per gene of each group were obtained using the 
Entrez Programming Utilities (E-utilities) and the R packages 
XML (version 3.98-1.19), httr, and biomart.
RESULTS
Longest and Shortest Genes
From all of the protein-coding genes in the human genome, 
a dataset was built selecting only the longest transcripts for 
each gene (N  =  19,714 genes; Supplementary Table S1). As 
our focus is on protein-coding regions, we  used the transcript 
length in our analysis, owing to the fact that there is a very 
strong correlation between the length of the longest transcript 
of a gene and its respective gene length (Kendall test: τ = 0.72, 
p  <  2.20E−16; Supplementary Figure S1). The five biggest 
genes in terms of transcript length have been studied previously, 
and they are associated with neuronal functions (Tao and 
Sampath, 2010; Yamagishi et al., 2011; Hu et al., 2016), cardiac 
tissue (Ware and Cook, 2017), and cancer (Felder et  al., 2014; 
Table  1). However, the smallest genes might be  annotation 
errors in the genome build.
We also built an additional dataset using the principal 
isoform based on APPRIS annotation (N  =  19,702; 
Supplementary Table S2A). We  found an overlap of 14,955 
transcripts between both datasets, resulting in a 75% overlap 
with the original transcript length-based dataset. Furthermore, 
the results presented in the following section were vastly similar 
to those obtained using the APPRIS dataset 
(Supplementary Table S2 and Supplementary Figure S2), and 
therefore we focused our analysis and discussion on the transcript 
length-based dataset.
Functional Analysis
One of the main objectives of the present study was to understand 
whether gene function was associated with gene length. Keeping 
this in mind, and using a list of the top  5% protein-coding 
genes with the longest and smallest transcript lengths, 
we performed a functional analysis using tools like WebGestalt 
(Liao et  al., 2019), DAVID (Huang et  al., 2009a,b), KEGG 
(Kanehisa and Goto, 2000), and Molecular Signature Database 
(Subramanian et  al., 2005; Liberzon et  al., 2015).
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For the genes with longer transcript lengths (Figure  1), 
most of the biological functions found seem to be  associated 
with the brain, specifically with regard to neurons. This can 
also be  confirmed when looking at the cellular component 
(Supplementary Figure S3A) and molecular function 
(Supplementary Figure S3B) and at the similar results produced 
using DAVID (Supplementary Table S3). The top 10% longest 
protein-coding genes produced similar results 
(Supplementary Table S3 and Supplementary Figures S3E–G).
For the genes with shorter transcript lengths (Figure  2), most 
of the biological functions found are related to the skin and the 
immune system. Cellular component (Supplementary Figure S3C), 
molecular function (Supplementary Figure S3D), and the DAVID 
(Supplementary Table S3) results support this observation. Again, 
the top 10% smallest protein-coding genes produced similar results 
(Supplementary Table S3 and Supplementary Figures S3H–J).
The results for the KEGG pathways (Figure  3A and 
Supplementary Figure S4) were color coded for each box 
plot based on their association with the terms we  found 
most relevant (brain, cancer, heart, immune system, muscle, 
neurodegenerative disease, skin, and others). For cases where 
there was no direct association, a literature search was done 
for relevant articles that showed that those pathways were 
related to the brain (Dermietzel and Spray, 1993; Fisher 
et  al., 2002; Funderburgh, 2002; Lasky and Wu, 2005; Lin 
et  al., 2006; Frere et  al., 2012; Kwok et  al., 2012; Monje 
et  al., 2012; Russo et  al., 2012; Bauer et  al., 2014; Kerrisk 
et al., 2014; Massaly et al., 2014; Mei and Nave, 2014; Stocker 
and Chenn, 2015; Schnaar, 2016; Zeng et al., 2016; Noelanders 
and Vleminckx, 2017; Grube et  al., 2018; Russo et  al., 2018; 
Dickson, 2019), cancer (Ogretmen, 2018), immune system 
(Prentki and Madiraju, 2008; Le Floc’h et  al., 2011; Barber, 
2014; Seif et  al., 2017; Zhang et  al., 2019), and the skin 
(Taylor et  al., 1991; Fisher and Voorhees, 1996; Iversen and 
Kragballe, 2000; Ziboh et  al., 2000; Slominski et  al., 2013). 
From the total 19,714 genes in our dataset, 5,203 (26%) 
were annotated with associations to KEGG pathways. The 
number of genes per pathway can be  found in 
Supplementary Table S4.
Looking at the KEGG pathway results for the longest transcript 
lengths, we  identified pathways associated with the brain, 
cancer, heart disease, and muscle (Figure  3A and 
Supplementary Figure S4), while the pathways with the shortest 
transcript lengths are mostly associated with the immune 
system; a few of them were also associated with the skin 
and neurodegenerative diseases (Figure  3B and 
Supplementary Figure S4).
The full KEGG results (186 gene sets) can be  found in 
Supplementary Figure S4, and the KEGG pathway IDs can 
be  found in Supplementary Table S4.
Finally, we wished to further understand the role of transcript 
length in the several functions of the immune system. Using 
the pathway database Reactome (Jassal et  al., 2019), 
we  investigated the distribution of transcript length at several 
ontology levels of the immune system. For the second ontology 
level, genes of the innate immune system (median  =  2,830) 
and of the cytokine signaling pathways (median  =  2,890) are 
significantly smaller than the genes from the adaptive immune 
system (median = 3,112), although the difference between them 
was not substantial (Supplementary Figure S5A). Regarding 
the third (Supplementary Figure S5B) and fourth 
(Supplementary Figure S5C) ontology levels, shorter genes 
appear to participate in the antimicrobial peptide pathway 
(defensins). Interestingly, part of the complement pathway 
(activation of C3 and C5; Supplementary Figure S5C) includes 
longer genes, but overall, the complement pathway 
(Supplementary Figure S5B) appears to be  on the shorter-
transcript-length side.
Gene Properties Correlated With 
Transcript Length
In order to understand the relationship between transcript length 
and other gene characteristics, a correlation analysis was performed. 
When looking at the number of SNPs for each transcript 
(Figure  4A), there was a significant positive correlation with 
transcript length (Kendall test: τ  =  0.45, p  <  2.20E−16). Similar 
results were found when comparing the number of SNPs per 
gene with gene length (Kendall test: τ  =  0.49, p  <  2.20E−16; 
Supplementary Figure S6A). After comparing the number of 
introns and the transcript length (Figure  4B), we  found a weak 
but significant positive correlation between these two variables 
(Kendall test: τ  =  0.35, p  <  2.20E−16). The strongest positive 
correlation (Kendall test: τ  =  0.48, p  <  2.20E−16) was the 
association with protein size (Figure 4C); the weakest correlation 
(Kendall test: τ  =  0.04, p  =  3.06E−14) was the association with 
average gene expression (Figure  4D).
Additionally, for the correlations with the transcript count 
(Supplementary Figure S6G) and GC content 
(Supplementary Figure S6H), we observed a weak but significant 
positive correlation (Kendall test: τ  =  0.22, p  <  2.20E−16) and 
a weak significant negative correlation (Kendall test: τ = −0.19, 
p  <  2.20E−16), respectively.
We were also interested in understanding the effect of transcript 
length in specific mutations. We  observed some strong and 
TABLE 1 | List of the top 5 longest protein-coding transcripts in the human genome.
Transcript stable ID Gene ID Gene name Transcript length Gene length Exon count Intron count Number of SNPs Protein size
  Longest genes
ENST00000589042 ENSG00000155657 TTN 109,224 118,976 363 362 69,258 35,991
ENST00000397910 ENSG00000181143 MUC16 43,816 43,830 84 83 38,498 14,507
ENST00000262160 ENSG00000175387 SMAD2 34,626 36,426 11 10 26,668 467
ENST00000330753 ENSG00000185070 FLRT2 33,681 34,901 2 1 25,451 660
ENST00000609686 ENSG00000273079 GRIN2B 30,355 30,941 13 12 90,195 1,484
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statistically significant correlations between transcript length and 
synonymous (Kendall test: τ  =  0.44, p  <  2.20E−16; 
Supplementary Figure S6I) and missense (Kendall test: τ = 0.42, 
p < 2.20E−16; Supplementary Figure S6J) mutations. However, 
in the case of nonsense mutations (Kendall test: τ  =  0.21, 
p  <  2.20E−16; Supplementary Figure S6K), a weaker but 
significant positive correlation with transcript length was observed. 
This was followed by the calculation of missense/synonymous 
(MIS/SYN) and nonsense/synonymous (NONS/SYN) rates in 
order to measure the functional importance of gene length. 
We observed that these ratios had similarly negative correlations 
with transcript length, with MIS/SYN having a weaker significant 
correlation (Kendall test: τ  =  −0.07, p  <  2.20E−16; 
Supplementary Figure S6L) than NONS/SYN (Kendall test: 
τ  =  −0.19, p  <  2.20E−16; Supplementary Figure S6M).
In order to better understand whether the correlations found 
were solely due to the transcript length or whether other factors 
were influencing them, we  built a correlation matrix with 
several gene characteristics (Figure  4E). We  observed that 
properties like intron counts, CDS length, protein size, number 
of SNPs, and transcript counts have strong positive correlations 
among themselves, some of which were stronger than any 
other correlations with transcript length. This indicates that 
the strong correlations with transcript length might not be due 
to the sole action of the transcript length itself, but rather 
due to the combined effects between several gene characteristics 
that also correlate with each other. Furthermore, partial 
correlations were performed for the number of SNPs (Kendall 
test: τ  =  0.27, p  <  2.20E−16), intron count (Kendall test: 
τ  =  −0.02, p  =  2.33E−05), protein size (Kendall test: τ  =  0.34, 
p < 2.20E−16), average gene expression (Kendall test: τ = 0.02, 
p  =  5.68E−07), transcript count (Kendall test: τ  =  0.05, 
p  <  2.20E−16), and GC content (Kendall test: τ  =  −0.09, 
p  <  2.20E−16) against transcript length while accounting for 
these other variables. The differences in the tau values between 
the correlations and partial correlations further illustrate that 
these variables are not independent of each other.
Distribution of Transcript Length and 
Expression in Human Tissues
In this present work, we  have found that the transcript length 
seems to peak at 2,065 bp, with smaller transcripts being more 
common than longer ones (Supplementary Figure S7A). As 
described previously (Gorlova et  al., 2014), the distribution of 
the number of introns in the human genome 
(Supplementary Figure S7B) has a mode of three introns, 
FIGURE 1 | Biological process Gene Ontology (GO) terms found associated with genes with the longest transcript length. Individual compartments represent each 
biological process term, and compartments were grouped based on semantic similarity. Compartment proportion is based on the false discovery rate (FDR) value. 
Overrepresentation enrichment analysis was performed with WebGestalt (Liao et al., 2019) and the visualization tool REViGO (Supek et al., 2011) was used to 
produce this figure. The significance level was p < 0.05 and the FDR was set at 0.05. FDR estimation was done using the Benjamini-Hochberg method. Full data 
available in Supplementary Table S2A.
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and there are very few genes with a large number of introns. 
The gene with the most introns is TTN, with 362 introns, 
which is also the gene with the longest transcript length.
To better understand the distribution of transcript length 
in human tissue expression, we  used tau values obtained from 
GTEx data (Palmer et  al., 2019). Tau was used as a measure 
of tissue specificity, based on the expression profile in different 
tissues, with values ranging from 0, for broadly expressed genes, 
to 1, for tissue-specific genes (Yanai et  al., 2005). For genes 
with a tau value above 0.8 (Figure  5 and 
Supplementary Figure S8 for the non-log-transformed version), 
we observed that longer tissue-specific genes are often associated 
with the blood vessel, nerve, thyroid, cervix uteri, and brain, 
while smaller tissue-specific genes are found in the pancreas, 
skin, stomach, vagina, and testis.
Aging and Transcript Length
Aging is an important factor in our lives, and it affects most 
organisms. We  were curious to see whether, for genes related 
to aging, the distribution of transcript length was significantly 
different from the rest of the protein-coding genes. We observed 
(Supplementary Figures S9A,B) that the genes associated with 
aging (N  =  307; Tacutu et  al., 2018) have longer transcript 
lengths (median  =  3,517) when compared with the rest of 
our dataset (median = 2,956) and that this difference of medians 
was significant (Wilcoxon rank-sum test: p  =  0.00036).
To further understand whether longer or smaller genes 
were more prominent with age, we  used genes from aging 
gene expression signatures obtained from a meta-analysis 
in human, mouse, and rat tissues (Palmer et  al., 2019). 
Genes from this signature were either overexpressed 
(NTotal  =  449, NBrain  =  147, NHeart  =  35, NMuscle  =  49) or 
underexpressed (NTotal = 162, NBrain = 16, NHeart = 5, NMuscle = 73) 
with age. Overall, the difference in the medians for the 
distribution of transcript length in the genes overexpressed 
(median  =  3,068) and underexpressed (median  =  3,026.5) 
with age was not observed to be  significant (Wilcoxon 
rank-sum test: p = 0.81; Supplementary Figure S9C). However, 
the tissue-specific signatures of aging show that the brain 
favors smaller genes with age (Wilcoxon rank-sum test: 
p = 0.00086, median for overexpression in the brain = 2,651, 
median for underexpression in the brain  =  5,824; 
Supplementary Figure S9D).
Evolution and Transcript Length
The relationship between intronic burden and evolution has 
been established before (Gorlova et  al., 2014), but very few 
studies approached this on a gene length front. Therefore, 
FIGURE 2 | Biological process Gene Ontology (GO) terms found associated with genes with the smallest transcript length. Individual compartments represent each 
biological process term, and compartments were grouped based on semantic similarity. Compartment proportion is based on the false discovery rate (FDR) value. 
Overrepresentation enrichment analysis was performed with WebGestalt (Liao et al., 2019) and the visualization tool REViGO (Supek et al., 2011) was used to 
produce this figure. The significance level was p < 0.05 and the FDR was set at 0.05. FDR estimation was done using the Benjamini-Hochberg method. Full data 
available in Supplementary Table S2B.
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we  obtained the dN and dS values for three organisms paired 
with human – mouse (Supplementary Figure S10A), gorilla 
(Supplementary Figure S10B), and chimpanzee 
(Supplementary Figure S10C) – and we  aimed to see how 
the distribution of transcript length happened in function of 
their dN/dS ratios. Overall, longer genes were associated with 
a dN/dS ratio less than 1 (the median transcript lengths are 
3,294, 3,377, and 3,338 for mouse, chimpanzee, and gorilla, 
respectively), while smaller genes seem to be  more associated 
with dN/dS ratios above or equal to 1 (the median transcript 
lengths are 1,171.5, 2,229.5, and 2,092 for mouse, chimpanzee, 
and gorilla, respectively), and the medians for both transcript 
length groups were always significantly different (Wilcoxon 
rank-sum test: p  =  0.00073 for mouse and p  <  2.2E−16 for 
both gorilla and chimpanzee).
Co-Expression Analysis and Protein-
Protein Interactions
Co-expression networks can help us better understand the 
functions of genes that are often expressed together and thus 
tend to be  functionally related (van Dam et  al., 2018). 
In order to determine whether gene length influenced the 
amount of co-expressed partners, we used data from GeneFriends 
(van Dam et al., 2015; Supplementary Table S5). We observed 
a weak correlation between transcript length and the number 
of co-expression partners in our dataset (Kendall test: τ = 0.10, 
p  <  2.2E−16; Supplementary Figure S11A). However, despite 
this weak correlation, longer genes appear to have more 
co-expressed gene partners than do smaller genes (Wilcoxon 
rank-sum test: p < 2.2E−16; Figure 6A; not-transformed figure 
in Supplementary Figure S11B, median values of the 
co-expression partners for longer genes = 2,725, median values 
of the co-expression partners for smaller genes = 32). We further 
analyzed the top and lower hundred human co-expressed genes 
from the GeneFriends database (Supplementary Table S5) 
and observed that the top highly co-expressed genes in the 
database have significantly longer transcript lengths (Wilcoxon 
rank-sum test: p  =  0.00072, median  =  3,880; 
Supplementary Figure S11C) with respect to the bottom ones 
(median  =  2,587.5).
FIGURE 3 | Transcript length distribution per Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway for the longest and smallest genes. Colors illustrate 
what the KEGG pathway has been directly associated with (B for brain, C for cancer, H for heart, IS for immune system, and ND for neurodegenerative diseases), 
due to it being stated in the pathway itself or indirectly associated with (Pub tag), by means of literature references. KEGG pathways and genes involved in said 
pathways were obtained from the Molecular Signature Database (Subramanian et al., 2005; Liberzon et al., 2015). (A) Top 20 pathways with the longest genes, 
ordered by median. (B) Top 20 pathways with the smallest genes, ordered by median.
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To determine whether transcript length also influenced the 
number of protein-protein interactions, we  used the protein-
protein interaction data from BioGRID (Stark, 2006; 
Supplementary Table S6). The results obtained were similar 
to the co-expression, where a weak correlation was observed 





FIGURE 4 | Correlation analysis between transcript length (in base pairs) and other gene characteristics. A 2D density plot can be found in Supplementary Figure 
S4B. Parts (A–D) have been logarithmically transformed in order to help visualize their relationship and/or account for the skewing introduced by outliers. The original 
versions of the figures can be found in Supplementary Figures S4C–F. (A) Correlation between the log-transformed number of single nucleotide polymorphisms 
(SNPs) and the log-transformed transcript length (in base pairs; Kendall test: τ = 0.45, p < 2.20E−16). The number of SNPs and the transcript length for each transcript 
were obtained using biomart. (B) Correlation between the number of introns and the log-transformed transcript length (in base pairs; Kendall test: τ = 0.35, 
p < 2.20E−16). The number of introns and the transcript length for each transcript were obtained using biomart. (C) Correlation between the log-transformed protein 
size (in amino acids) and the log-transformed transcript length (in base pairs; Kendall test: τ = 0.48, p < 2.20E−16). Protein size and transcript length were obtained 
using biomart. (D) Correlation between the average gene expression and the log-transformed transcript length (in base pairs; Kendall test: τ = 0.04, p = 3.06E−14). 
Average gene expression was obtained from the UCSC Genome browser; this value was derived from the total median expression level across all tissues and was 
based on the GTEx project. Transcript length was obtained using biomart. (E) Correlation matrix between gene properties. Kendall’s test was used as a measurement of 
correlation, with the numbers and the gradient of colors symbolizing the tau values for each comparison. The values for the number of SNPs are for each transcript. 
Values that are crossed out are not statistically significant. Values are clustered together based on their tau values.
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interactions (Kendall test: τ  =  0.06, p  <  2.2E−16; 
Supplementary Figure S12A).
To ascertain that the interactions found were not due to 
publication bias, we  obtained the number of publications for 
each gene from PubMed and compared these to gene length 
and to the number of interactions (Figure  6B). We  observed 
that the number of interactions and publications were significantly 
different between each gene length group (Wilcoxon rank-sum 
test: p  <  2.2E−16 for both comparisons), with both being 
higher for the group comprising longer length genes. In order 
to assess the level of influence of publication bias in our 
protein-protein interaction dataset, we used correlations between 
the values of protein-protein interactions and the number of 
publications, and we observed that, for both gene length groups, 
the correlations were not the strongest (Kendall test: longest 
genes, τ  =  0.26, p  <  2.2E−16; smallest genes, τ  =  0.36, 
p  <  2.2E−16), implying that while there might be  some 
publication bias in effect, the strength of that effect is rather 
weak. To further support this, we  carried out a multivariable 
regression to determine the influence of the number of 
publications and transcript length in the number of 
protein-protein interactions (PPI) found (p of F 
statistic  =  1.936E−10). We  again observed that the number 
of publications did not have a significant association with the 
number of PPI (t  =  1.41, p  =  1.59E−1), unlike transcript 
length (t  =  6.55, p  =  6.06E−11). This resulted in the model 
being extremely inaccurate (R2  =  0.0022, residual standard 
error  =  78.05).
In the group of the longest genes, 208 (21%) entries had 
zero protein-protein interactions, while for the smallest group 
of genes, 544 (55%) entries had zero protein-protein interactions. 
This means that there were either no physical interactions for 
those genes or that there were no entries in BioGRID for 
them. So as to account for this, and similarly to what we  did 
for the co-expression analysis, we  extracted the top  100 genes 
with the most and fewest protein-protein interactors (without 
null values) in our dataset and observed the distribution of 
their transcript length. We  observed that the genes with the 
most protein-protein interactions were longer (median transcript 
length  =  3,737) than the genes with the smallest amount of 
protein-protein interactions (Wilcoxon rank-sum test: p = 0.039, 
median transcript length = 2,764; Supplementary Figure S12B).
FIGURE 5 | Log-transformed transcript length distribution for genes specifically expressed in the given tissues. Tissue specificity was defined as a gene having a 
tau specificity score greater than 0.8.
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DISCUSSION
With this work, we  tried to elucidate the factors associated with 
gene length and, in particular, whether gene length is associated 
with the function of the resulting proteins in the cell. Even 
looking at the five longest genes, we  can get a small glimpse 
into the possible functions associated with gene length. TTN 
is the longest transcript in the human genome and serves several 
important functions in the skeletal and cardiac muscles and is 
often involved in structure, sensory, and signaling responses 
(Chauveau et  al., 2014; Savarese et  al., 2016; Ware and Cook, 
2017). The mucin MUC16 (or CA125) is mostly known as a 
biomarker in ovarian cancer and is used to monitor patients 
as an indicator of cancer recurrence (Felder et al., 2014; Haridas 
et al., 2014; Das and Batra, 2015). Furthermore, MUC16 normally 
functions as a protector of epithelial cells (Haridas et  al., 2014). 
SMAD family member 2 (SMAD2) is thought to play a critical 
role in neuronal function (Tao and Sampath, 2010) and to have 
a protective role in hepatic fibrosis (Xu et  al., 2016). The gene 
FLRT2 is believed to have a role in tumor suppression in breast 
and prostate cancers (Wu et  al., 2016; Bae et  al., 2017), and in 
mouse models, FLRT2 has been found as a guiding agent in 
neuronal and vascular cells (Yamagishi et  al., 2011; Seiradake 
et  al., 2014). For the GRIN2B gene, it has been shown to play 
an important role in neuronal development and in cell 
differentiation in the brain (Hu et  al., 2016; Bell et  al., 2018). 
We  cannot obtain any information at the moment pertaining 
to the function of the five smallest genes since all of them are 
either novel and have yet to be  properly studied and, indeed, 
could be  annotation errors in the human genome assembly.
In order to understand the effects of gene length on protein 
function, we  performed a functional analysis. For longer genes, 
the GO terms obtained were mostly associated with neurons; 
for example, terms like axon development, axon part, neuron-
to-neuron synapse, actin and cell polarity (Polleux and Snider, 
2010), and GTPases (Polleux and Snider, 2010). For tissue-specific 
genes, the brain and nerves also had the longest genes. Looking 
at the KEGG pathways associated with the longest genes, the 
categories present are in the brain, cancer, heart diseases, and 
muscle. Previous studies have associated longer genes with neurons 
A
B
FIGURE 6 | Co-expression and protein-protein interaction results pertaining to the longest and the smallest genes. The High group corresponds to the top 5% longest 
genes found in our original dataset (NHigh = 986), while the Low group corresponds to the top 5% smallest genes found in our original dataset (NLow = 986). (A) Distribution of 
the log-ransformed number of co-expressed genes for the long genes and the small genes. The number of co-expressed genes were obtained from data publicly available 
in GeneFriends (van Dam et al., 2015). (B) Distribution of the number of protein-protein interactions and the number of publications for longer and smaller genes, all log-
transformed. The number of protein-protein interactions were obtained from BioGRID (Stark, 2006) and the number of publications obtained from PubMed.
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(Zylka et al., 2015; Takeuchi et al., 2018; McCoy and Fire, 2020) 
and muscle (Hosokawa et  al., 2019). Due to the very nature 
of longer genes, one expects high rates of mutation, not only 
due to their size but also due to possible collisions between 
the RNA polymerase and the DNA polymerase, which cause 
instability and possible mutations (Helmrich et  al., 2011). It is 
not surprising to find associations between longer genes and 
cancer (Sahakyan and Balasubramanian, 2016) and heart 
pathologies often caused by mutations in particularly long genes, 
like DSC2 and TTN (Jefferies and Towbin, 2010; Maron and 
Maron, 2013; Corrado et  al., 2017).
Looking at smaller genes, most of the GO terms were 
associated with the skin, for example skin development and 
cornified envelope, or with the immune system, for example, 
defense response to other organisms and receptor agonist 
activity. Smaller tissue-specific genes also have a major presence 
in the skin. With regard to the KEGG pathways associated 
with the smaller genes, most pathways were involved in the 
immune system, with a few also being present in 
neurodegenerative diseases and in the skin. In addition, the 
Reactome immune system pathway with the smallest genes 
was found to be  associated with antimicrobial peptides 
(defensins). Defensins are small peptides that play a role in 
innate immunity and have been found to be  expressed in 
several mammal species (Holly et  al., 2017). Moreover, the 
complement cascade, another important function in the innate 
immune system, was also associated with smaller genes for 
the most part, with a specific pathway (activation of C3 and 
C5) being the exception. Previous studies have observed that 
most genes associated with immune functions are rather small 
in size (Pipkin and Monticelli, 2008). However, to our knowledge, 
there are no previous studies to support the association of 
smaller genes with skin development.
In spite of this, our findings led us to believe that there 
is a disparity in gene sizes for genes that have a role or are 
present in tissues with very little to almost no development 
postnatally (like neurons) and for genes (not involved in 
housekeeping) that are quite frequently expressed during a 
human’s whole lifetime (like in skin development and immune 
response) or are involved in functions that require fast responses. 
Corroborating our findings for the functional analysis, a recent 
preprint has showed that, with age, there is a downregulation 
of long transcripts and an upregulation of short transcripts, 
in a phenomena they named “length-driven transcriptome 
imbalance,” which, in humans, affects the brain the most (Stoeger 
et  al., 2019). As we  observed, smaller genes can be  associated 
with the immune system – and inflammation has a role in 
many aging-related diseases (Goldberg and Dixit, 2015) – while 
longer genes are mostly associated with brain development, a 
function that happens early in life.
In terms of gene characteristics, there was no strong correlation 
with transcript length. The strongest positive correlations were 
with protein size and number of SNPs, with transcript count, 
number of introns, GC content, and average gene expression 
having a weak significant positive correlation.
The correlation we observed between average gene expression 
and transcript length was not in line with previous observations, 
which suggested that highly expressed genes are often shorter 
in length (Urrutia and Hurst, 2003). We  observed that, among 
smaller genes, the average gene expression was, in fact, the 
highest (Supplementary Figure S6F). However, shorter genes 
also had a great variability in the average gene expression 
values, and there was almost no correlation between transcript 
length and average gene expression. What has been stated in 
the previous studies is relevant, but the whole image is not 
captured properly. Rather than stating that the smaller genes 
are highly expressed, it is more accurate to say that smaller 
genes have a greater variability of levels of expression than 
longer genes. Previous studies have shown that the length of 
messenger RNA (mRNA) will affect the translation dynamics, 
with smaller mRNAs producing more proteins (in both normal 
and cancer cells) than their longer counterparts, a phenomenon 
that may be due to energy conservation in the case of translation 
errors or misfolding (Valleriani et  al., 2011; Wang et  al., 2013; 
Guo et  al., 2015). This matches with what we  observed as 
well: smaller genes will have a more important role in day-to-day 
functions due to their ability to be  rapidly translated and in 
more numbers; on the other hand, longer genes are important 
for early life development, especially in the brain and heart, 
where it would be  worth spending more energy in more long-
lasting, robust functions.
While the observation that the number of SNPs is correlated 
with transcript length is not surprising since, logically, longer 
genes will have a higher probability of accumulating more 
mutations than smaller genes, it is unexpected that the correlation 
was not stronger. To further explore this, we  used different 
mutation ratios and observed their relationship with transcript 
length. Similar to the correlation results for the number of 
SNPs, both synonymous and missense mutations were also 
highly correlated with transcript length. It is particularly 
interesting that the correlation values were so high for missense 
mutations since these may cause loss of function in the resulting 
protein. Likewise, it could be  one of the reasons why the 
correlation between nonsense mutations and transcript length 
is weaker than that for synonymous and missense mutations. 
Other works (Gorlova et  al., 2014) have used the MIS/SYN 
and NONS/SYN ratios as a measure of functional importance, 
where, if a gene is important in terms of its function, it will 
be  less tolerant toward the accumulation of missense and 
nonsense mutations. We observed that there was a, albeit faint, 
negative correlation between the ratios MIS/SYN and NONS/
SYN and transcript length, which, based on the notions in 
the work of Gorlova et  al., would imply that longer genes 
appear to be  more functionally important than smaller genes. 
The negative correlation between the ratios MIS/SYN and 
NONS/SYN showed that longer genes may have more mechanisms 
in place to prevent loss-of-function mutations when compared 
with synonymous mutations. Moreover, we have to take account 
of “outliers” when looking into the correlation between transcript 
length and protein size (Supplementary Figure S6E), specifically 
for longer genes. One would expect that, for longer genes, 
the proteins produced would have a size comparable to their 
length and not be extremely small. However, some long transcripts 
result in small proteins due to the presence of very long 3’ 
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UTR regions. While these regions still account for the calculation 
of transcript and gene size, they are not translated into the 
protein, causing the presence of these “outliers.” Previous studies 
have shown that the brain has a preference for these long 3’ 
UTR regions (Miura et  al., 2013; Wang and Yi, 2014).
Interestingly, we  noticed that genes associated with aging 
tend to be  longer than the rest of the protein-coding genome. 
Moreover, we also showed that the overall (not tissue-dependent) 
expression of genes with age appears to be  unrelated to 
transcript length and that the brain seems to favor the 
expression of smaller genes with age. The latter result is in 
line with the observations by Stoeger et  al. (2019) who also 
witnessed an upregulation of smaller transcripts with age, 
especially in the brain. These results also make sense because 
small genes are often associated with immune function, which 
is often upregulated with age (de Magalhães et  al., 2009). 
Furthermore, Palmer et  al. (2019) observed that the genes 
overexpressed with age in the brain were mostly associated 
with immune functions. However, our results pertaining to 
the overall expression of genes with age are different from 
what Stoeger et  al. (2019) observed that transcript length is 
an important source of aging-dependent changes in expression. 
It is possible that these differences between our results and 
those of Stoeger et  al. (2019) are due to differences in the 
underlying datasets.
When comparing gene length with the dN/dS ratio for three 
organisms (gorilla, chimpanzee, and mouse), longer genes appear 
to evolve under stronger evolutionary constraints. Previous 
studies have shown that, for genes classified as “old” (by virtue 
of having orthologs in older organisms), their length will 
be  longer, they will have more introns, and they evolve more 
slowly than smaller genes (Wolf et al., 2009; Vishnoi et al., 2010).
In terms of the co-expression analysis and protein-protein 
interactions, the longer genes, in general, had the most 
co-expression partners and protein-protein interactions. Further 
validating our observations, we  also saw that the top hundred 
highest co-expression genes and PPI were longer in length as 
compared to the lowest co-expression genes and PPI. In light 
of these results, it is important to point out that gene length 
is a potential bias in large-scale genomic and systems biology 
studies that scientists should be  aware of.
Not all genes are studied at the same depth. Some genes have 
more information related to expression or function than others. 
We  observed this especially within our list of the 5% longest 
and smallest genes. Longer length genes had more functional 
information than shorter ones. We also observed that longer genes 
have more associated publications than smaller genes. Indeed, 
other groups have found that gene length can be  an important 
predictor of the number of publications and that novel genes are 
not often studied to their full capacity (Stoeger et  al., 2018), 
while others have found that genetic associations tend to be 
more biased toward longer genes (Mirina et  al., 2012;  
de Magalhães and Wang, 2019).
The present study has its limitations. One of the limitations 
for this sort of study is that the results might be “time-specific.” 
With new discoveries related to the human genome and its 
genes, the trends here observed might change, specifically when 
it concerns the currently untapped field of smaller genes. 
Similarly, as we previously noted, longer genes have a lot more 
information related to them when compared with their smaller 
counterparts. While our findings with respect to the longer 
genes might be more reliable, we cannot have the same confidence 
in the case of the smaller genes, considering that a lot of 
these genes have yet to be  properly studied. Moreover, while 
smaller genes might be  annotation errors, they could also 
be  pseudo-genes or even non-coding genes that possess an 
open reading frame (ORF) that were missed when Ensembl 
scanned for pseudo-genes. Even after taking into account the 
above limitations, however, the present study still provides 
novel insights pertaining to gene length and its possible role 
in early life development, diseases, and response time in the 
human genome.
CONCLUSION
In this work, we aimed to further understand the relationships 
between gene length (mostly using the length of a gene’s longest 
transcript as a proxy for gene length) and gene function as 
well as factors associated with gene length. We  observed that, 
for most of the factors studied, there was not a particularly 
strong correlation with transcript length. The strongest 
correlations were observed with the number of SNPs and 
protein size. We  also showed that, for smaller genes, their 
association with high levels of expression is not entirely correct 
and that, instead, there is great variability of expression values 
among them. We  also observed that longer genes appear to 
have more co-expression partners and protein-protein interactions 
in comparison to their smaller counterparts.
At the functional level, we  observed that longer genes tend 
to be  associated with functions in the brain, cancer, heart, 
and muscle, while smaller genes are associated with the immune 
system, skin, and neurodegenerative diseases. This led us to 
believe that gene length could be associated with the frequency 
of usage of the gene, with longer genes being less often used 
past development and smaller genes playing a frequent role 
daily in the human body, like the immune system.
In conclusion, gene size does matter: longer genes tend to 
have more SNPs, are more likely to be important in development, 
have more interactions, and, ultimately, are more studied.
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